iCardiac Technologies

company

About

iCardiac Technologies is a laboratory that develops cardiac safety biomarkers which provide assessments of drugs in development.

  • 51 - 100

Details

Last Funding Type
Series B
Industries
Biopharma,Biotechnology,Health Care,Life Science
Founded date
Jan 1, 2006
Number Of Employee
51 - 100
Operating Status
Active

iCardiac Technologies, Inc. develops cardiac safety biomarkers. The company offers Dynamic QTbtbsm, a suite of ECG-based cardiac safety markers that delivers assessment of the cardiac safety profile of drugs in development. Its technology is used in cardiac clinical trials conducted by pharmaceutical, biotechnology, and medical device companies. The company’s services include scientific and medical consultation, study design, data and project management, ECG analysis, statistical reporting, data submission, and interface with the regulators. iCardiac Technologies, Inc. was founded in 2006 and is headquartered in Rochester, New York.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$4M
iCardiac Technologies has raised a total of $4M in funding over 2 rounds. Their latest funding was raised on Mar 6, 2014 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 6, 2014 Series Unknown 1 Detail
Nov 14, 2007 Series B 2 Detail
Nov 8, 2006 Series A $4M 1 Advantage Capital Detail

Investors

Number of Lead Investors
Number of Investors
1
3
iCardiac Technologies is funded by 3 investors. Norwest Venture Partners and Advantage Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Norwest Venture Partners Series Unknown
Advantage Capital Series B
Stonehenge Growth Capital Series B